(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC7A1 mRNA] CTD PMID:31150632 (-)-alpha-phellandrene decreases expression ISO RGD:736349 6480464 alpha phellandrene results in decreased expression of SLC7A1 mRNA CTD PMID:25075043 1,1-dichloroethene increases expression ISO RGD:11316 6480464 vinylidene chloride results in increased expression of SLC7A1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:11316 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC7A1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:11316 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC7A1 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of SLC7A1 mRNA CTD PMID:20551477 more ... 17beta-estradiol increases expression ISO RGD:736349 6480464 Estradiol results in increased expression of SLC7A1 mRNA CTD PMID:31614463 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:11316 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:11316 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:11316 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC7A1 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC7A1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736349 6480464 Tetrachlorodibenzodioxin affects the expression of SLC7A1 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736349 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC7A1 mRNA CTD PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:11316 6480464 Tetrachlorodibenzodioxin affects the expression of SLC7A1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC7A1 mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO RGD:736349 6480464 2 more ... CTD PMID:26705709 2-butoxyethanol increases expression ISO RGD:11316 6480464 n-butoxyethanol results in increased expression of SLC7A1 mRNA CTD PMID:19812364 2-methylcholine affects expression ISO RGD:736349 6480464 beta-methylcholine affects the expression of SLC7A1 mRNA CTD PMID:21179406 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:11316 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of SLC7A1 mRNA CTD PMID:20188158 3-Iodothyronamine affects uptake ISO RGD:736349 6480464 SLC7A1 mRNA affects the uptake of 3-iodothyronamine CTD PMID:19074582 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of SLC7A1 mRNA CTD PMID:25380136 4-hydroxyphenyl retinamide increases expression ISO RGD:11316 6480464 Fenretinide results in increased expression of SLC7A1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLC7A1 mRNA CTD PMID:24780913 8-Br-cAMP increases expression ISO RGD:736349 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of SLC7A1 mRNA CTD PMID:22079614 acetamide affects expression EXP 6480464 acetamide affects the expression of SLC7A1 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SLC7A1 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:736349 6480464 Acrylamide results in increased expression of SLC7A1 mRNA CTD PMID:32763439 aflatoxin B1 decreases expression ISO RGD:11316 6480464 Aflatoxin B1 results in decreased expression of SLC7A1 mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:736349 6480464 Aflatoxin B1 results in increased methylation of SLC7A1 intron CTD PMID:30157460 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SLC7A1 mRNA CTD PMID:25378103 aflatoxin B1 increases expression ISO RGD:736349 6480464 Aflatoxin B1 results in increased expression of SLC7A1 mRNA CTD PMID:22100608 alachlor increases expression EXP 6480464 alachlor results in increased expression of SLC7A1 mRNA CTD PMID:12419858 all-trans-retinoic acid decreases expression ISO RGD:736349 6480464 Tretinoin results in decreased expression of SLC7A1 mRNA CTD PMID:16054129 , PMID:33167477 alpha-phellandrene decreases expression ISO RGD:736349 6480464 alpha phellandrene results in decreased expression of SLC7A1 mRNA CTD PMID:25075043 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC7A1 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of SLC7A1 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO RGD:736349 6480464 aristolochic acid I results in decreased expression of SLC7A1 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:736349 6480464 arsenite inhibits the reaction [G3BP1 protein binds to SLC7A1 mRNA] CTD PMID:32406909 arsenous acid increases expression ISO RGD:736349 6480464 Arsenic Trioxide results in increased expression of SLC7A1 mRNA CTD PMID:20458559 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SLC7A1 gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO RGD:736349 6480464 Benzo(a)pyrene results in decreased expression of SLC7A1 mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO RGD:736349 6480464 Benzo(a)pyrene results in increased expression of SLC7A1 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:736349 6480464 Benzo(a)pyrene results in increased methylation of SLC7A1 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:11316 6480464 Benzo(a)pyrene results in increased expression of SLC7A1 mRNA CTD PMID:21569818 , PMID:32417428 benzo[a]pyrene decreases expression ISO RGD:11316 6480464 Benzo(a)pyrene results in decreased expression of SLC7A1 mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:736349 6480464 7 more ... CTD PMID:19150397 benzo[e]pyrene increases methylation ISO RGD:736349 6480464 benzo(e)pyrene results in increased methylation of SLC7A1 intron CTD PMID:30157460 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC7A1 mRNA CTD PMID:18164116 bexarotene decreases expression ISO RGD:736349 6480464 bexarotene results in decreased expression of SLC7A1 mRNA CTD PMID:17178900 bisphenol A decreases expression ISO RGD:736349 6480464 bisphenol A results in decreased expression of SLC7A1 mRNA CTD PMID:20678512 bisphenol A decreases methylation ISO RGD:736349 6480464 bisphenol A results in decreased methylation of SLC7A1 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:736349 6480464 bisphenol A results in increased expression of SLC7A1 mRNA CTD PMID:33670352 bisphenol A affects expression ISO RGD:736349 6480464 bisphenol A affects the expression of SLC7A1 mRNA CTD PMID:30903817 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC7A1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:11316 6480464 bisphenol A results in decreased expression of SLC7A1 mRNA CTD PMID:26063408 bleomycin A2 decreases expression ISO RGD:11316 6480464 Bleomycin results in decreased expression of SLC7A1 mRNA CTD PMID:30825431 bleomycin A2 multiple interactions ISO RGD:11316 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SLC7A1 mRNA], lenabasum inhibits the reaction [Bleomycin results in decreased expression of SLC7A1 mRNA] CTD PMID:30825431 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of SLC7A1 mRNA CTD PMID:32479839 calcitriol decreases expression ISO RGD:736349 6480464 Calcitriol results in decreased expression of SLC7A1 mRNA CTD PMID:16002434 cannabidiol multiple interactions ISO RGD:11316 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in decreased expression of SLC7A1 mRNA] CTD PMID:30825431 carbamazepine affects expression ISO RGD:736349 6480464 Carbamazepine affects the expression of SLC7A1 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:11316 6480464 Nanotubes, Carbon results in increased expression of SLC7A1 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:736349 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC7A1 gene] CTD PMID:28238834 chloroacetaldehyde decreases expression ISO RGD:736349 6480464 chloroacetaldehyde results in decreased expression of SLC7A1 mRNA CTD PMID:25596134 chlorpyrifos increases expression ISO RGD:11316 6480464 Chlorpyrifos results in increased expression of SLC7A1 mRNA CTD PMID:34289071 cidofovir anhydrous increases expression ISO RGD:736349 6480464 Cidofovir results in increased expression of SLC7A1 mRNA CTD PMID:25596134 cisplatin decreases phosphorylation ISO RGD:11316 6480464 Cisplatin results in decreased phosphorylation of SLC7A1 protein CTD PMID:22006019 cisplatin increases expression ISO RGD:736349 6480464 Cisplatin results in increased expression of SLC7A1 mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:736349 6480464 Cisplatin results in decreased expression of SLC7A1 mRNA CTD PMID:27594783 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of SLC7A1 mRNA CTD PMID:22023808 cobalt dichloride decreases expression ISO RGD:736349 6480464 cobaltous chloride results in decreased expression of SLC7A1 mRNA CTD PMID:19320972 cobalt dichloride increases expression ISO RGD:736349 6480464 cobaltous chloride results in increased expression of SLC7A1 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:736349 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC7A1 mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:736349 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC7A1 mRNA CTD PMID:24690739 coumestrol multiple interactions ISO RGD:736349 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A1 mRNA CTD PMID:19167446 crocidolite asbestos affects expression ISO RGD:736349 6480464 Asbestos, Crocidolite affects the expression of SLC7A1 mRNA CTD PMID:25757056 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SLC7A1 mRNA CTD PMID:27523638 cyclosporin A increases expression ISO RGD:11316 6480464 Cyclosporine results in increased expression of SLC7A1 mRNA CTD PMID:19770486 cyclosporin A increases expression ISO RGD:736349 6480464 Cyclosporine results in increased expression of SLC7A1 mRNA CTD PMID:20106945 more ... diarsenic trioxide increases expression ISO RGD:736349 6480464 Arsenic Trioxide results in increased expression of SLC7A1 mRNA CTD PMID:20458559 dibutyl phthalate increases expression ISO RGD:11316 6480464 Dibutyl Phthalate results in increased expression of SLC7A1 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of SLC7A1 mRNA CTD PMID:21266533 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of SLC7A1 mRNA CTD PMID:18636392 diclofenac decreases expression ISO RGD:11316 6480464 Diclofenac results in decreased expression of SLC7A1 mRNA CTD PMID:35537566 dicrotophos increases expression ISO RGD:736349 6480464 dicrotophos results in increased expression of SLC7A1 mRNA CTD PMID:28302478 dioxygen increases expression ISO RGD:11316 6480464 Oxygen deficiency results in increased expression of SLC7A1 mRNA CTD PMID:24205000 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of SLC7A1 mRNA CTD PMID:33729688 dioxygen multiple interactions ISO RGD:11316 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC7A1 mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:736349 6480464 Oxygen deficiency results in increased expression of SLC7A1 mRNA CTD PMID:25596134 disulfiram multiple interactions ISO RGD:736349 6480464 [Disulfiram binds to Copper] which results in increased expression of SLC7A1 mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO RGD:736349 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:736349 6480464 Doxorubicin results in decreased expression of SLC7A1 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of SLC7A1 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:736349 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of SLC7A1 mRNA CTD PMID:19167446 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of SLC7A1 mRNA CTD PMID:25596134 fenofibrate increases expression ISO RGD:736349 6480464 Fenofibrate results in increased expression of SLC7A1 mRNA CTD PMID:25596134 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of SLC7A1 mRNA CTD PMID:30307764 fluoranthene multiple interactions ISO RGD:11316 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A1 mRNA, SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A1 mRNA] CTD PMID:28329830 folic acid multiple interactions ISO RGD:11316 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC7A1 mRNA CTD PMID:22206623 ibuprofen increases expression ISO RGD:736349 6480464 Ibuprofen results in increased expression of SLC7A1 mRNA CTD PMID:25596134 indometacin increases expression EXP 6480464 Indomethacin results in increased expression of SLC7A1 mRNA CTD PMID:16184411 ivermectin decreases expression ISO RGD:736349 6480464 Ivermectin results in decreased expression of SLC7A1 protein CTD PMID:32959892 lead diacetate increases expression ISO RGD:11316 6480464 lead acetate results in increased expression of SLC7A1 mRNA CTD PMID:25270620 leflunomide increases expression ISO RGD:736349 6480464 leflunomide results in increased expression of SLC7A1 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO RGD:11316 6480464 [nickel sulfate co-treated with Lipopolysaccharides] results in increased expression of SLC7A1 mRNA CTD PMID:23415871 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of SLC7A1 mRNA CTD PMID:28801915 metformin increases expression EXP 6480464 Metformin results in increased expression of SLC7A1 mRNA CTD PMID:25596134 methapyrilene increases methylation ISO RGD:736349 6480464 Methapyrilene results in increased methylation of SLC7A1 intron CTD PMID:30157460 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SLC7A1 mRNA CTD PMID:30467583 methylmercury chloride increases expression ISO RGD:736349 6480464 methylmercuric chloride results in increased expression of SLC7A1 mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:736349 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A1 mRNA CTD PMID:27188386 motexafin gadolinium multiple interactions ISO RGD:736349 6480464 [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC7A1 mRNA CTD PMID:16357179 motexafin gadolinium increases expression ISO RGD:736349 6480464 motexafin gadolinium results in increased expression of SLC7A1 mRNA CTD PMID:16357179 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine decreases expression ISO RGD:736349 6480464 N more ... CTD PMID:12756304 N-methyl-4-phenylpyridinium increases expression ISO RGD:736349 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC7A1 mRNA CTD PMID:24810058 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SLC7A1 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC7A1 mRNA CTD PMID:18164116 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of SLC7A1 mRNA CTD PMID:25380136 nickel sulfate multiple interactions ISO RGD:11316 6480464 [nickel sulfate co-treated with Lipopolysaccharides] results in increased expression of SLC7A1 mRNA CTD PMID:23415871 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC7A1 mRNA CTD PMID:25729387 ozone increases expression EXP 6480464 Ozone results in increased expression of SLC7A1 mRNA CTD PMID:16716893 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of SLC7A1 mRNA CTD PMID:18636392 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC7A1 mRNA CTD PMID:30723492 , PMID:33387578 paraquat affects expression EXP 6480464 Paraquat affects the expression of SLC7A1 mRNA CTD PMID:16854511 paraquat increases expression ISO RGD:736349 6480464 Paraquat results in increased expression of SLC7A1 mRNA CTD PMID:34097952 paraquat increases expression EXP 6480464 Paraquat results in increased expression of SLC7A1 mRNA CTD PMID:32680482 PCB138 multiple interactions ISO RGD:11316 6480464 [2 more ... CTD PMID:25510870 perfluorononanoic acid increases expression ISO RGD:736349 6480464 perfluoro-n-nonanoic acid results in increased expression of SLC7A1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid increases expression ISO RGD:736349 6480464 perfluorooctane sulfonic acid results in increased expression of SLC7A1 mRNA CTD PMID:32588087 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of SLC7A1 mRNA CTD PMID:19162173 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of SLC7A1 mRNA CTD PMID:18158353 phorone affects expression EXP 6480464 phorone affects the expression of SLC7A1 mRNA CTD PMID:18198479 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of SLC7A1 mRNA CTD PMID:12832660 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of SLC7A1 mRNA CTD PMID:28374803 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC7A1 protein CTD PMID:35544339 SB 203580 multiple interactions ISO RGD:11316 6480464 SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC7A1 mRNA] CTD PMID:28329830 SB 431542 multiple interactions ISO RGD:736349 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:11316 6480464 Silicon Dioxide results in increased expression of SLC7A1 mRNA CTD PMID:23221170 silicon dioxide decreases expression ISO RGD:736349 6480464 Silicon Dioxide results in decreased expression of SLC7A1 mRNA CTD PMID:25351596 sodium arsenite increases expression ISO RGD:736349 6480464 sodium arsenite results in increased expression of SLC7A1 mRNA CTD PMID:29301061 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of SLC7A1 mRNA CTD PMID:25993096 Soman increases expression EXP 6480464 Soman results in increased expression of SLC7A1 mRNA CTD PMID:19281266 sulindac increases expression ISO RGD:736349 6480464 Sulindac results in increased expression of SLC7A1 mRNA CTD PMID:11906190 sunitinib increases expression ISO RGD:736349 6480464 Sunitinib results in increased expression of SLC7A1 mRNA CTD PMID:31533062 tetrachloromethane affects expression ISO RGD:11316 6480464 Carbon Tetrachloride affects the expression of SLC7A1 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO RGD:11316 6480464 Carbon Tetrachloride results in increased expression of SLC7A1 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC7A1 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC7A1 mRNA, Carbon Tetrachloride results in increased expression of SLC7A1 protein CTD PMID:17544377 more ... thapsigargin increases expression ISO RGD:736349 6480464 Thapsigargin results in increased expression of SLC7A1 mRNA CTD PMID:22378314 , PMID:29453283 thimerosal decreases expression ISO RGD:736349 6480464 Thimerosal results in decreased expression of SLC7A1 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC7A1 mRNA CTD PMID:34492290 toluene increases expression EXP 6480464 Toluene results in increased expression of SLC7A1 mRNA CTD PMID:22967744 topiramate decreases expression EXP 6480464 topiramate results in decreased expression of SLC7A1 mRNA CTD PMID:16979414 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC7A1 mRNA CTD PMID:25729387 triazines multiple interactions ISO RGD:11316 6480464 Triazines inhibits the reaction [IDH2 protein mutant form results in decreased expression of SLC7A1 mRNA] CTD PMID:27469509 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC7A1 mRNA CTD PMID:33387578 trichostatin A affects expression ISO RGD:736349 6480464 trichostatin A affects the expression of SLC7A1 mRNA CTD PMID:28542535 triclosan decreases expression ISO RGD:736349 6480464 Triclosan results in decreased expression of SLC7A1 mRNA CTD PMID:30510588 trovafloxacin decreases expression ISO RGD:11316 6480464 trovafloxacin results in decreased expression of SLC7A1 mRNA CTD PMID:35537566 tunicamycin increases expression ISO RGD:736349 6480464 Tunicamycin results in increased expression of SLC7A1 mRNA CTD PMID:22378314 , PMID:29453283 urethane increases expression ISO RGD:736349 6480464 Urethane results in increased expression of SLC7A1 mRNA CTD PMID:28818685 valproic acid decreases methylation ISO RGD:736349 6480464 Valproic Acid results in decreased methylation of SLC7A1 gene CTD PMID:29154799 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SLC7A1 mRNA CTD PMID:29427782 valproic acid multiple interactions ISO RGD:736349 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC7A1 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:736349 6480464 Valproic Acid results in increased expression of SLC7A1 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:736349 6480464 Valproic Acid affects the expression of SLC7A1 mRNA CTD PMID:25979313 vancomycin decreases expression ISO RGD:11316 6480464 Vancomycin results in decreased expression of SLC7A1 mRNA CTD PMID:18930951 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SLC7A1 mRNA CTD PMID:23034163 zinc acetate multiple interactions ISO RGD:736349 6480464 [Zinc Acetate co-treated with motexafin gadolinium] affects the expression of SLC7A1 mRNA CTD PMID:16357179 zinc acetate increases expression ISO RGD:736349 6480464 Zinc Acetate results in increased expression of SLC7A1 mRNA CTD PMID:16357179